This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wieneke, C. A.
Right arrow Articles by Schell, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wieneke, C. A.
Right arrow Articles by Schell, R. F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2000, p. 313-317, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evaluation of Whole-Cell and OspC Enzyme-Linked Immunosorbent Assays for Discrimination of Early Lyme Borreliosis from OspA Vaccination

Chad A. Wieneke,1,2,dagger Steven D. Lovrich,1,* Steven M. Callister,1,3 Dean A. Jobe,1 Jennifer A. Marks,1 and Ronald F. Schell2,4

Microbiology Research Laboratory1 and Section of Infectious Diseases,3 Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601, and Department of Medical Microbiology and Immunology2 and Wisconsin State Laboratory of Hygiene,4 University of Wisconsin, Madison, Wisconsin 53706

Received 21 May 1999/Returned for modification 23 September 1999/Accepted 14 October 1999

A recombinant Lyme borreliosis vaccine consisting of outer surface protein A (OspA) is commercially available for vaccination of humans against infection with Borrelia burgdorferi. Vaccination with OspA induces an antibody response that makes serologic interpretation of infection with B. burgdorferi difficult, especially by screening tests based on whole-cell preparations of B. burgdorferi. We show that an enzyme-linked immunosorbent assay with B. burgdorferi sensu stricto 50772, which lacks the plasmid encoding OspA and OspB, or a full-length recombinant OspC protein can identify patients infected with B. burgdorferi. We found that 69 and 65% of serum samples from patients with case-defined early Lyme borreliosis had anti-B. burgdorferi sensu stricto 50772 and anti-OspC reactivities, respectively. In addition, little or no reactivity was detected with sera obtained from individuals vaccinated with OspA. Unfortunately, 51 and 33% of sera from healthy patients and sera from patients with other illnesses were also reactive against B. burgdorferi sensu stricto 50772 and OspC, respectively. Although these assays can discriminate B. burgdorferi infection from vaccination with OspA, their lack of specificity highlights the necessity for confirming equivocal or positive reactivities with more specific serodiagnostic tests.


* Corresponding author. Mailing address: Microbiology Research Laboratory, Gundersen Lutheran Medical Center, 1836 South Ave., La Crosse, WI 54601. Phone: (608) 782-7300, ext. 3743. Fax: (608) 791-6602. E-mail: slovrich{at}centuryinter.net.

dagger Present address: R&D Systems, Minneapolis, MN 55413.


Journal of Clinical Microbiology, January 2000, p. 313-317, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Jobe, D. A., Lovrich, S. D., Asp, K. E., Mathiason, M. A., Albrecht, S. E., Schell, R. F., Callister, S. M. (2008). Significantly Improved Accuracy of Diagnosis of Early Lyme Disease by Peptide Enzyme-Linked Immunosorbent Assay Based on the Borreliacidal Antibody Epitope of Borrelia burgdorferi OspC. CVI 15: 981-985 [Abstract] [Full Text]  
  • Lovrich, S. D., La Fleur, R. L., Jobe, D. A., Johnson, J. C., Asp, K. E., Schell, R. F., Callister, S. M. (2007). Borreliacidal OspC Antibody Response of Canines with Lyme Disease Differs Significantly from That of Humans with Lyme Disease. CVI 14: 635-637 [Abstract] [Full Text]  
  • Lovrich, S. D., Jobe, D. A., Schell, R. F., Callister, S. M. (2005). Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or Hamsters. CVI 12: 746-751 [Abstract] [Full Text]  
  • Jobe, D. A., Lovrich, S. D., Schell, R. F., Callister, S. M. (2003). C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme Disease. CVI 10: 573-578 [Abstract] [Full Text]  
  • Jespersen, D. J., Smith, T. F., Rosenblatt, J. E., Cockerill III, F. R. (2002). Comparison of the Borrelia DotBlot G, MarDx, and VIDAS Enzyme Immunoassays for Detecting Immunoglobulin G Antibodies to Borrelia burgdorferi in Human Serum. J. Clin. Microbiol. 40: 4782-4784 [Abstract] [Full Text]  
  • Hefty, P. S., Brooks, C. S., Jett, A. M., White, G. L., Wikel, S. K., Kennedy, R. C., Akins, D. R. (2002). OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients. J. Clin. Microbiol. 40: 4256-4265 [Abstract] [Full Text]  
  • PANELIUS, J., LAHDENNE, P., HEIKKILA, T., PELTOMAA, M., OKSI, J., SEPPALA, I. (2002). Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. J Med Microbiol 51: 731-739 [Abstract] [Full Text]  
  • Marques, A. R., Martin, D. S., Philipp, M. T. (2002). Evaluation of the C6 Peptide Enzyme-Linked Immunosorbent Assay for Individuals Vaccinated with the Recombinant OspA Vaccine. J. Clin. Microbiol. 40: 2591-2593 [Abstract] [Full Text]  
  • Gomes-Solecki, M. J. C., Wormser, G. P., Schriefer, M., Neuman, G., Hannafey, L., Glass, J. D., Dattwyler, R. J. (2002). Recombinant Assay for Serodiagnosis of Lyme Disease Regardless of OspA Vaccination Status. J. Clin. Microbiol. 40: 193-197 [Abstract] [Full Text]